Zimmer Biomet (NYSE:ZBH) is a global leader in musculoskeletal healthcare, specializing in the design, manufacture and marketing of orthopaedic reconstructive products, including joint replacement implants and related surgical instruments. The company’s product portfolio spans hip and knee replacements, shoulder and elbow implants, spinal and trauma devices, sports medicine solutions and dental reconstructive products. Zimmer Biomet also offers biologics, surgical power tools and digital solutions aimed at improving patient outcomes and supporting healthcare professionals throughout the continuum of care.
Tracing its roots to the founding of Zimmer in Warsaw, Indiana in 1927 and Biomet in Warsaw, Indiana in 1977, the combined Zimmer Biomet entity emerged in 2015 following the merger of the two companies. Over nearly a century, the company has built a reputation for innovation in orthopaedics, introducing new biomaterials and advanced manufacturing techniques. Today, Bryan C. Hanson serves as President and Chief Executive Officer, leading a management team focused on operational excellence, research and development, and strategic growth initiatives.
Zimmer Biomet’s core business activities center on developing and commercializing advanced orthopaedic solutions for joint reconstruction, spinal care, trauma management and dental applications. Its reconstruction portfolio features a range of knee systems, hip systems and shoulder implants engineered to restore mobility and relieve pain. In the spine and trauma segment, the company offers fixation systems, biologic products and minimally invasive surgical solutions. Complementing its implant offerings, Zimmer Biomet provides comprehensive surgical instruments, robotic-assisted technologies and pre- and post-operative digital planning tools.
With operations in more than 25 countries and product distribution in over 100 markets, Zimmer Biomet serves surgeons, hospitals and dental practices worldwide. Manufacturing facilities span North America, Europe and Asia, supported by a global sales and marketing network. The company invests in collaborative research partnerships and educational programs aimed at advancing musculoskeletal health and providing training for healthcare professionals. Through this extensive reach and ongoing innovation, Zimmer Biomet remains committed to enhancing patient quality of life and driving progress in orthopaedic care.
